News
News from the BioCity Campus

tediro receives a significant six-figure research grant from the Thuringian development bank for the further development of the mobile robotics platform

Ilmenau/Leipzig, November 9, 2021 – The mobile robotics platform of tediro GmbH facilitates a large number of therapies and diagnoses, relieves the increasing documentation effort and supports patients and therapists in ensuring high treatment quality. The Thuringian development bank has also recognized the advantages of this innovation and supports the further development of the mobile robotic platform for therapy and diagnostics. 

“With the grant we are financing our first version of the product and the development of our cloud-based therapy management system. This also covers patients doing exercises on stairs, as well as limited weight bearing when walking with crutches, which is to be introduced in a later product,” says Anke Mayfarth, co-founder and managing director of tediro continues to support research related to our mobile robot after we received a grant to a research consortium consisting of our partners TU Ilmenau, MetraLabs and Waldkliniken Eisenberg in 2016," adds co-founder and managing director Christian Sternitzke.  

The tediro GmbH currently provides several Hire for this project, including robotics and cloud software engineers, product managers and the like. 

About tediro GmbH 

The company tediro is developing the world's first mobile therapy and diagnostics robot, which is to take over a large number of routine activities in clinics in the future. Initially, the focus is on AI-supported rehabilitation. Here, tediro relies on established robot navigation technologies and develops the medical applications as digital therapy and diagnostic procedures on the robot both itself and in cooperation with partners. 

 

Source: News www.tediro.com by 09.11.2021


previous news

c-LEcta – Market launch of a newly developed medical product: NuCLEANase®

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, is launching a newly developed enzyme product: NuCLEANase® is a highly active endonuclease that breaks down all forms of DNA and RNA.

NextNews

COME ON BABY LIGHT MY FIRE - New medical technology forge in Saxony

Fire comes from coal – in Leipzig, the federal government’s structural change program to phase out lignite will result in an accelerator program for MedTech start-ups that will also create sparks – MEDICAL FORGE.